Review





Similar Products

95
MedChemExpress bromo
Bromo, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bromo/product/MedChemExpress
Average 95 stars, based on 1 article reviews
bromo - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

99
NSJ Bioreagents bromodeoxyuridine / brdu antibody
Bromodeoxyuridine / Brdu Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bromodeoxyuridine / brdu antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
bromodeoxyuridine / brdu antibody - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

86
Servicebio Inc brdu
Res-PD-L1@nmEVs Attenuate Inflammation and Oxidative Damage in Lung Epithelial Cells In Vitro . (A-B) Flow cytometric analysis and quantification (B) of DiO-labeled Res-PD-L1@nmEVs uptake by BEAS-2B cells under H/R conditions after pretreatment with different endocytic inhibitors (chlorpromazine, chloroquine, and filipin) or incubation at 4 °C. (C) mRNA expression levels of IL-6, TNF-α, and IL-1β in BEAS-2B cells with or without H/R injury following pretreatment with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs. (D-E) Representative fluorescence images (D) and quantitative analysis (E) of <t>cell</t> <t>proliferation</t> assessed by <t>BrdU</t> incorporation (red; nuclei stained with DAPI, blue). Scale bar: 50 μm. (F-G) Apoptosis rates detected by flow cytometry (F) and flow cytometric analysis of Annexin V-positive BEAS-2B cells under the indicated conditions (G). (H–K) Fluorescence microscopy images and quantitative analysis of intracellular nitric oxide (NO, green) (H-I) and reactive oxygen species (ROS, red) (J-K). Scale bar: 100 μm. (L) Flow cytometry analysis of intracellular ROS levels. (M − O) Levels of malondialdehyde (MDA) (M), superoxide dismutase 2 (SOD2) activity (N), and glutathione (GSH) content (O) in cells. (P-Q) Cell migration ability evaluated by wound healing assay under different treatments. ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.
Brdu, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
brdu - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Servicebio Inc brdu kits
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) <t>Cell</t> <t>proliferation</t> detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
Brdu Kits, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu kits/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
brdu kits - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Servicebio Inc brdu elisa kit
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
Brdu Elisa Kit, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu elisa kit/product/Servicebio Inc
Average 86 stars, based on 1 article reviews
brdu elisa kit - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Covance brdu labeling index
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
Brdu Labeling Index, supplied by Covance, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu labeling index/product/Covance
Average 86 stars, based on 1 article reviews
brdu labeling index - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Hermetia Baruth giemsa brdu 5 bromodeoxyurdine edta ethylenediaminetetraacetic acid dmso dimethyl sulfoxide fitc fluorescein isothiocyanate
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
Giemsa Brdu 5 Bromodeoxyurdine Edta Ethylenediaminetetraacetic Acid Dmso Dimethyl Sulfoxide Fitc Fluorescein Isothiocyanate, supplied by Hermetia Baruth, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/giemsa brdu 5 bromodeoxyurdine edta ethylenediaminetetraacetic acid dmso dimethyl sulfoxide fitc fluorescein isothiocyanate/product/Hermetia Baruth
Average 86 stars, based on 1 article reviews
giemsa brdu 5 bromodeoxyurdine edta ethylenediaminetetraacetic acid dmso dimethyl sulfoxide fitc fluorescein isothiocyanate - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
MedChemExpress 5 bromo2 deoxyuridine brdu
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
5 Bromo2 Deoxyuridine Brdu, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/5 bromo2 deoxyuridine brdu/product/MedChemExpress
Average 95 stars, based on 1 article reviews
5 bromo2 deoxyuridine brdu - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

95
MedChemExpress brdu
Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine <t>(BrdU)</t> staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).
Brdu, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/brdu/product/MedChemExpress
Average 95 stars, based on 1 article reviews
brdu - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

Image Search Results


Res-PD-L1@nmEVs Attenuate Inflammation and Oxidative Damage in Lung Epithelial Cells In Vitro . (A-B) Flow cytometric analysis and quantification (B) of DiO-labeled Res-PD-L1@nmEVs uptake by BEAS-2B cells under H/R conditions after pretreatment with different endocytic inhibitors (chlorpromazine, chloroquine, and filipin) or incubation at 4 °C. (C) mRNA expression levels of IL-6, TNF-α, and IL-1β in BEAS-2B cells with or without H/R injury following pretreatment with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs. (D-E) Representative fluorescence images (D) and quantitative analysis (E) of cell proliferation assessed by BrdU incorporation (red; nuclei stained with DAPI, blue). Scale bar: 50 μm. (F-G) Apoptosis rates detected by flow cytometry (F) and flow cytometric analysis of Annexin V-positive BEAS-2B cells under the indicated conditions (G). (H–K) Fluorescence microscopy images and quantitative analysis of intracellular nitric oxide (NO, green) (H-I) and reactive oxygen species (ROS, red) (J-K). Scale bar: 100 μm. (L) Flow cytometry analysis of intracellular ROS levels. (M − O) Levels of malondialdehyde (MDA) (M), superoxide dismutase 2 (SOD2) activity (N), and glutathione (GSH) content (O) in cells. (P-Q) Cell migration ability evaluated by wound healing assay under different treatments. ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

Journal: Bioactive Materials

Article Title: Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia–reperfusion lung injury and pneumonia

doi: 10.1016/j.bioactmat.2026.03.024

Figure Lengend Snippet: Res-PD-L1@nmEVs Attenuate Inflammation and Oxidative Damage in Lung Epithelial Cells In Vitro . (A-B) Flow cytometric analysis and quantification (B) of DiO-labeled Res-PD-L1@nmEVs uptake by BEAS-2B cells under H/R conditions after pretreatment with different endocytic inhibitors (chlorpromazine, chloroquine, and filipin) or incubation at 4 °C. (C) mRNA expression levels of IL-6, TNF-α, and IL-1β in BEAS-2B cells with or without H/R injury following pretreatment with Res, nEVs, PD-L1@mEVs, PD-L1@nmEVs, or Res-PD-L1@nmEVs. (D-E) Representative fluorescence images (D) and quantitative analysis (E) of cell proliferation assessed by BrdU incorporation (red; nuclei stained with DAPI, blue). Scale bar: 50 μm. (F-G) Apoptosis rates detected by flow cytometry (F) and flow cytometric analysis of Annexin V-positive BEAS-2B cells under the indicated conditions (G). (H–K) Fluorescence microscopy images and quantitative analysis of intracellular nitric oxide (NO, green) (H-I) and reactive oxygen species (ROS, red) (J-K). Scale bar: 100 μm. (L) Flow cytometry analysis of intracellular ROS levels. (M − O) Levels of malondialdehyde (MDA) (M), superoxide dismutase 2 (SOD2) activity (N), and glutathione (GSH) content (O) in cells. (P-Q) Cell migration ability evaluated by wound healing assay under different treatments. ∗ vs. Control; # vs. H/R; & vs. H/R + PD-L1@nmEVs, p < 0.05.

Article Snippet: For cell proliferation assessment, cells were pre-treated with BrdU (40 μM, GC310002 , Servicebio) for 4 h and incubated with anti-BrdU antibody at 4 °C overnight.

Techniques: In Vitro, Labeling, Incubation, Expressing, Fluorescence, BrdU Incorporation Assay, Staining, Flow Cytometry, Microscopy, Activity Assay, Migration, Wound Healing Assay, Control

Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

Journal: Cell Reports Medicine

Article Title: Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury

doi: 10.1016/j.xcrm.2026.102768

Figure Lengend Snippet: Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

Article Snippet: Cell proliferation was assessed using BrdU kits ( GC310002 , Servicebio) and Cell Counting Kit-8 (CCK-8) assays (C0041, Beyotime) per manufacturer protocols.

Techniques: Labeling, Adsorption, Incubation, Centrifugation, Cell Counting, CCK-8 Assay, Irradiation, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Gene Expression, Immunofluorescence, Expressing, Staining, BrdU Staining, Flow Cytometry, Control

Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

Journal: Cell Reports Medicine

Article Title: Macrophage-mimetic photothermal nanotherapeutics regulate mitochondrial homeostasis and inflammatory cascades in lung ischemia-reperfusion injury

doi: 10.1016/j.xcrm.2026.102768

Figure Lengend Snippet: Targeted repair of hypoxia/reoxygenation (H/R)-injured lung epithelial cells by Rg3@PACVs (A) Cellular uptake of Dio-labeled Rg3@PACVs (green) by H/R-injured BEAS-2B cells. Fluorescent localization was analyzed with or without pretreatment of endocytosis inhibitors (filipin, chlorpromazine, or chloroquine) (scale bars, 20 μm). (B–E) Cytokine adsorption capacity assessed by co-incubation of Rg3@PACVs (500 or 250 μg/mL) with inflammatory cytokines (IL-6, TNF-α, IL-1β, and CCL-2). Cytokine concentrations in supernatants were measured after centrifugation ( ∗∗∗ p < 0.001 vs. 0 μg/mL; # p < 0.05, ## p < 0.01 vs. 250 μg/mL; n = 3 biological replicates). (F) Cell viability of H/R-treated BEAS-2B cells assessed by cell counting kit-8 (CCK-8) assay. Cells were treated with Rg3, PACVs, or Rg3@PACVs with or without near-infrared (NIR) irradiation. (G–I) Real-time quantitative polymerase chain reaction (RT-qPCR) analysis of inflammatory gene expression (IL-6, IL-1β, and TNF-α) in H/R-stimulated BEAS-2B cells under different pretreatment conditions. (J) Immunofluorescence showing expression and co-localization of NLRP3 (green) and COX2 (red) in H/R-injured lung epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 100 μm. (K) Cell proliferation detected by bromodeoxyuridine (BrdU) staining (red) in the above epithelial cells. Nuclei stained with DAPI (blue). Scale bars, 50 μm. (L) Apoptosis ratio analyzed by flow cytometry using Annexin V-Allophycocyanin (Annexin V-APC) and 7-Aminoactinomycin D (7-AAD) staining. Data are presented as the mean ± SD and analyzed using one-way ANOVA (B–E and G–I) and two-way ANOVA (F) with Tukey’s post hoc test (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001 vs. control; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. H/R; & p < 0.05, && p < 0.01, &&& p < 0.001 vs. H/R + Rg3@PACVs; n = 3 biological replicates, for F–I).

Article Snippet: BrdU ELISA kit , Servicebio , Cat# GC310002.

Techniques: Labeling, Adsorption, Incubation, Centrifugation, Cell Counting, CCK-8 Assay, Irradiation, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Gene Expression, Immunofluorescence, Expressing, Staining, BrdU Staining, Flow Cytometry, Control